Vaccine Therapy or Observation in Treating Patients With Nasopharyngeal Cancer at High Risk for Recurrence - Related Studies

Vaccine Therapy or Observation in Treating Patients With Nasopharyngeal Cancer at High Risk for Recurrence

This study is ongoing, but not recruiting participants.

Study NCT00112541. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Head and Neck Cancer

2	Additional conditions recognized in this trial
		Head and Neck Neoplasms
		Nasopharyngeal Neoplasms

3	More general conditions related to this trial
		Nasopharyngeal Diseases
		Neoplasms
		Neoplasms by Site
		Otorhinolaryngologic Diseases
		Otorhinolaryngologic Neoplasms
		Pharyngeal Diseases
		Pharyngeal Neoplasms
		Stomatognathic Diseases

4	Interventions listed in this trial
		LMP-2:340-349 peptide vaccine
		LMP-2:419-427 peptide vaccine
		incomplete Freund's adjuvant
		adjuvant therapy

5	Additional drug interventions recognized in this trial
		Freund's Adjuvant

6	More general drug interventions related to this trial
		Adjuvants, Immunologic
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		NCI - Center for Cancer Research-Medical Oncology
		National Cancer Institute (NCI)